Please login to the form below

Not currently logged in
Email:
Password:

Bridge Biotherapeutics

This page shows the latest Bridge Biotherapeutics news and features for those working in and with pharma, biotech and healthcare.

FDA clears wider use for Boehringer’s Ofev in lung disease

FDA clears wider use for Boehringer’s Ofev in lung disease

followed earlier deals with Bridge Biotherapeutics for an Ofev follow-up and Yuhan focusing on lover fibrosis.

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...